Device Trial Radar · NCT07793604
Increasing Mitochondrial Respiration as a Novel Mechanism for Cognitive Augmentation
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Oct 1, 2026
Primary completion
Dec 2029
Study completion May 2030
Sponsor
- Lead sponsor
- Francisco Gonzalez-Lima, PhDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 28, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the effects of increasing brain energy on cognition. The hypothesis is that by using a special kind of light, in combination with a nutritional supplement, it may be possible to increase energy production in the brain, which may lead to improvements in cognition.
Conditions
- Cognition Improvement
- Emotion Regulation
Interventions
Active transcranial photobiomodulationDevice
Infrared light delivered to the forehead, administered with a headset using light-emitting diodes (LEDs)
Active MCT dietary supplementationDietary supplement
Commercially-available food-grade refined coconut oil for ketogenic dietary supplementation
Sham photobiomodulationDevice
Identical procedure as active group, but with 5% of light emitted by the device.
Sham dietary supplementationDietary supplement
Identical appearance and administration as active dietary supplementation, but with commercially-available food-grade sunflower oil (comparable caloric value without ketone production).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cognitive assessment: Montreal Cognitive Assessment (MoCA)Time frame: The MoCA will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)
- Cognitive assessment: Trail-Making TestTime frame: The TMT will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)
- Brain metabolism assessment: Functional Near-Infrared Spectroscopy (fNIRS)Time frame: The fNIRS procedure will be administered: 1. Pre-treatment (during Visit 1); 2. Post-treatment (Visit 2, two months later)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The University of Texas at Austin
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.